| 注册
首页|期刊导航|转化医学杂志|中药调节肠道菌群及代谢物改善代谢相关脂肪性肝病研究进展

中药调节肠道菌群及代谢物改善代谢相关脂肪性肝病研究进展

翟家明 何恒 何康乐

转化医学杂志2025,Vol.14Issue(2):269-276,8.
转化医学杂志2025,Vol.14Issue(2):269-276,8.DOI:10.3639/i.issn.2095-3097.2025.02.052

中药调节肠道菌群及代谢物改善代谢相关脂肪性肝病研究进展

Research Progress on Traditional Chinese Medicine in Treating Metabolism-Related Fatty Liver Disease via Regulating Gut Microbiota and Metabolites

翟家明 1何恒 1何康乐1

作者信息

  • 1. 246000 安徽 安庆,安庆一一六医院
  • 折叠

摘要

Abstract

Metabolism-related fatty liver disease(MAFLD)is an increasingly serious liver disease,essentially manifesting as a multi-system metabolic dysfunction.Disease spectrum that affects the liver not only included liver diseases like fatty liver hepatitis,liver fibrosis,cirrhosis,and liver cancer,but also extrahepatic diseases like type 2 diabetes mellitus,atherosclerosis,and chronic kidney disease.Traditional Chinese medicine(TCM)regulates the structure and function of gut microbiota,which improves beneficial bacteria and lower the growth of harmful bacteria,thereby restoring the Yin-Yang balance of gut microbiota,alleviating lipid accumulation and inflammatory response within the liver,and preventing and treating MAFLD.This article reviewed the research progress of TCM in improving MAFLD,analyzed the role of TCM in mediating MAFLD via regulating gut microbiota and metabolites,and explored clinical and basic research findings.Our review provided theoretical references of TCM in treating MAFLD,and issued the current challenges and future research direction.

关键词

中药/肠道菌群/代谢物/代谢相关脂肪性肝病/研究进展

Key words

Traditional Chinese medicine/Gut microbiota/Metabolites/Metabolism-related fatty liver disease/Research progress

分类

医药卫生

引用本文复制引用

翟家明,何恒,何康乐..中药调节肠道菌群及代谢物改善代谢相关脂肪性肝病研究进展[J].转化医学杂志,2025,14(2):269-276,8.

转化医学杂志

2095-3097

访问量0
|
下载量0
段落导航相关论文